Diabetes :: American Indians and Alaska Natives at risk for Diabetes

About 40 percent of adults ages 40 to 74 –
or 41 million people – have pre-diabetes, a condition that
raises a person’s risk of developing type 2 diabetes, heart
disease, and stroke. American Indians and Alaska Natives
are 2.3 times as likely to have diabetes as non-Hispanic
whites of similar age.

Fibromyalgia :: Chronic pain illness – FM – Fibromyalgia

Fibromyalgia is a complex chronic pain illness that is recognized by the American Medical Association, the National Institutes of Health and the American College of Rheumatology. FM experts estimate that approximately 5% of the population worldwide suffer with FM. While it is most common in women, the illness strikes men, women and children of all ages and ethnic backgrounds. For those with severe symptoms, FM can be extremely debilitating and interfere with even routine daily activities.

Internet websites promoting bogus cures

The lives of thousands of cancer patients are at risk due to internet websites promoting bogus cures which can cause more harm than good, new research warned.

Mesothelioma :: Lung cancer – Asbestosis – Mesothelioma

The National Cancer Institute states that: “Malignant mesothelioma, a rare form of cancer (Lung cancer), is a disease in which cancer (malignant) cells are found in the sac lining the chest (the pleura), the lining of the abdominal cavity (the peritoneum) or the lining around the heart (the pericardium).

Rare Diseases: New Help for Patients Without Treatments

Years ago, people diagnosed with a rare disease might have found themselves
with little hope for a medical treatment. This changed in 1983 when American Congress
passed the Orphan Drug Act, a law that offered drug companies special
incentives to develop products for treating diseases with fewer than 200,000
patients a year. The inducements include seven-year marketing exclusivity, tax
credit for the product-associated clinical research, research design assistance
by the FDA, and grants of up to $300,000 per year.

Hyperhidrosis :: Botulinum – Botox to treat severe underarm sweating

FDA has approved Botulinum Toxin Type A (Botox) to treat severe underarm sweating known as primary axillary hyperhidrosis that cannot be managed by topical agents such as prescription antiperspirants. Botox has already been approved for several other purposes. Today?s approval allows the product?s manufacturer, Allergan, Inc., Irvine, Calif., to market Botulinum Toxin Type A for this new indication.

Dr. Anil Singhal Homeopathic Doctor | Dr. Anil Singhal's Blog | Manan - My Memoir by Dr. Anil Singhal | Boger's Legacy | Organon of Medicine | Health Newstrack